UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000045176
Receipt number R000051613
Scientific Title Relationship between vitamin D concentration and sarcopenia in chronic liver diseas
Date of disclosure of the study information 2021/08/18
Last modified on 2021/08/17 17:53:43

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Relationship between vitamin D concentration and sarcopenia in chronic liver disease

Acronym

Relationship between vitamin D concentration and sarcopenia

Scientific Title

Relationship between vitamin D concentration and sarcopenia in chronic liver diseas

Scientific Title:Acronym

Relationship between vitamin D concentration and sarcopenia

Region

Japan


Condition

Condition

chronic hepatitis

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Examine the relationship between sarcopenia and vitamin D concentration

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Relationship between Vitamin D concentration and presence / absence of sarcopenia, muscle mass, and muscle strength

Key secondary outcomes

Relationship between sarcopenia, muscle mass, strength and other endpoints


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with chronic liver disease (including chronic hepatitis, cirrhosis, and decompensated cirrhosis)
20 years and over
Patients who usually undergo an abdominal CT examination (simple or contrast-enhanced) including lumbar spine L3 at the time of outpatient examination or hospitalization

Key exclusion criteria

No exclusion criteria

Target sample size

500


Research contact person

Name of lead principal investigator

1st name TOMOMI
Middle name
Last name OKUBO

Organization

Nippon Medical School Chiba Hokuso Hospital

Division name

Gastroenterology

Zip code

2701613

Address

1715 Kamagari Inzai Chiba

TEL

0476991111

Email

ma6-0154@nms.ac.jp


Public contact

Name of contact person

1st name TOMOMI
Middle name
Last name OKUBO

Organization

Nippon Medical School Chiba Hokuso Hospiital

Division name

Gastroenterology

Zip code

2701613

Address

1715 Kamagari Inzai Chiba

TEL

0476991111

Homepage URL


Email

ma6-0154@nms.ac.jp


Sponsor or person

Institute

Nippon Medical Chiba Hokuso Hospital

Institute

Department

Personal name



Funding Source

Organization

Nippon Medical Chiba Hokuso Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nippon Medical School Chiba Hokouso Hospital

Address

1715 Kamagari Inzai Chiba

Tel

0476991111

Email

araraki@nms.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2021 Year 08 Month 18 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2021 Year 03 Month 04 Day

Date of IRB

2021 Year 03 Month 04 Day

Anticipated trial start date

2021 Year 03 Month 04 Day

Last follow-up date

2025 Year 01 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

CT will be used to measure muscle mass and diagnose sarcopenia. In addition, the muscle mass at the third lumbar vertebra level required for sarcopenia diagnosis from the abdominal CT image is analyzed using the software built into the computer for analysis. For the diagnosis of sarcopenia, the criteria for sarcopenia (1st edition) proposed by the Japanese Society of Hepatology are used.


Management information

Registered date

2021 Year 08 Month 17 Day

Last modified on

2021 Year 08 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000051613


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name